Learn More
BACKGROUND The virulence, antimicrobial resistance, and prevalence of S. aureus underscores the need for up-to-date and extensive insights regarding antimicrobial susceptibility trends. One approach to meet this need is analysis of clinical laboratory-based surveillance data. METHODS Data from The Surveillance Network-USA (TSN), an electronic surveillance(More)
BACKGROUND Reporting all adverse events (AEs) and serious adverse events (SAEs) in substance use disorder (SUD) clinical trials has yielded limited relevant safety information and has been burdensome to research sites. OBJECTIVE This article describes a new strategy utilizing standard data elements for AE and SAEs that defines a threshold to reduce(More)
  • 1